Inhibition of mitochondrial complexes I and IV by 6-hydroxydopamine
- 24 March 1995
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology: Environmental Toxicology and Pharmacology
- Vol. 292 (3-4) , 329-332
- https://doi.org/10.1016/0926-6917(95)90040-3
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- MRI, brain iron and experimental Parkinson's diseaseJournal of the Neurological Sciences, 1992
- Mechanisms of cell deathArchives of Toxicology, 1991
- The Iron Chelator Desferrioxamine (Desferal) Retards 6‐Hydroxydopamine‐Induced Degeneration of Nigrostriatal Dopamine NeuronsJournal of Neurochemistry, 1991
- Manganese and calcium efflux kinetics in brain mitochondria. Relevance to manganese toxicityBiochemical Journal, 1990
- Deficiencies in Complex I subunits of the respiratory chain in Parkinson's diseaseBiochemical and Biophysical Research Communications, 1989
- N‐Methyl‐4‐phenylpyridine (MMP+ together with 6‐hydroxydopamine or dopamine stimulates Ca2+ release from mitochondriaFEBS Letters, 1986
- Redox state of cytochrome C in the presence of the 6-hydroxydopamine/oxygen couple: Oscillations dependent on the presence of hydrogen peroxide or superoxideArchives of Biochemistry and Biophysics, 1984